EMA Withdrawn: Humenza (split influenza virus, inactivated, containing antigen*: A/California/7/2009 (H1N1)v like strain (X-179A)*propagated in eggs.) — Sanofi Pasteur S.A.

View source ↗

Summary

EMA has withdrawn the Humenza influenza vaccine from the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disease Outbreaks
• Immunization

Drugs mentioned

• Humenza

Snippet

Status: Withdrawn. Therapeutic area: Influenza, Human;Immunization;Disease Outbreaks. MAH: Sanofi Pasteur S.A.. Decision date: 14/06/2011. Conditional approval